LASSBio-1135 is a dual TRPV1 antagonist and TNF-alpha production inhibitor. References: Lima CK, Silva RM, Lacerda RB, Santos BL, Silva RV, Amaral LS, Quintas LE, Fraga CA, Barreiro EJ, Guimaraes MZ, Miranda AL. LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain. PLoS One. 2014 Jun 18;9(6):e99510. doi: 10.1371/journal.pone.0099510. eCollection 2014. PubMed PMID: 24941071; PubMed Central PMCID: PMC4062389.

纯度：≥98%

CAS：852453-71-5